Polymeric delivery formulations of leuprolide with improved efficacy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9254307
APP PUB NO 20100234305A1
SERIAL NO

12784343

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to a flowable composition that is suitable for use as a controlled release implant. The flowable composition includes a biodegradable thermoplastic polyester that is at least substantially insoluble in aqueous medium or body fluid. The flowable composition also includes a biocompatible polar aprotic solvent. The biocompatible polar aprotic solvent is miscible to dispersible in aqueous medium or body fluid. The flowable composition also includes leuprolide acetate.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TOLMAR THERAPEUTICS INC701 CENTER AVENUE FORT COLLINS CO 80526

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chandrashekar, Bhagya L Fort Collins, US 11 803
Dunn, Richard L Fort Collins, US 79 9381
Garrett, John Steven Fort Collins, US 8 364
Ravivarapu, Harish Union City, US 14 417

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 9, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00